- Home
- ESPR vs ONEW Comparison
ESPR vs ONEW Comparison
Compare ESPR & ONEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- ONEW
- Stock Information
- Founded
- ESPR 2008
- ONEW 2014
- Country
- ESPR United States
- ONEW United States
- Employees
- ESPR N/A
- ONEW N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- ONEW Auto & Home Supply Stores
- Sector
- ESPR Health Care
- ONEW Consumer Discretionary
- Exchange
- ESPR Nasdaq
- ONEW Nasdaq
- Market Cap
- ESPR 208.1M
- ONEW 244.4M
- IPO Year
- ESPR 2013
- ONEW 2020
- Fundamental
- Price
- ESPR $0.85
- ONEW $14.77
- Analyst Decision
- ESPR Buy
- ONEW Buy
- Analyst Count
- ESPR 7
- ONEW 7
- Target Price
- ESPR $5.93
- ONEW $19.83
- AVG Volume (30 Days)
- ESPR 6.2M
- ONEW 180.1K
- Earning Date
- ESPR 05-06-2025
- ONEW 07-29-2025
- Dividend Yield
- ESPR N/A
- ONEW N/A
- EPS Growth
- ESPR N/A
- ONEW N/A
- EPS
- ESPR N/A
- ONEW N/A
- Revenue
- ESPR $259,574,000.00
- ONEW $1,779,631,000.00
- Revenue This Year
- ESPR $4.07
- ONEW $1.77
- Revenue Next Year
- ESPR N/A
- ONEW $4.88
- P/E Ratio
- ESPR N/A
- ONEW N/A
- Revenue Growth
- ESPR 12.99
- ONEW N/A
- 52 Week Low
- ESPR $0.69
- ONEW $11.58
- 52 Week High
- ESPR $3.94
- ONEW $31.36
- Technical
- Relative Strength Index (RSI)
- ESPR 44.65
- ONEW 52.57
- Support Level
- ESPR $0.79
- ONEW $13.41
- Resistance Level
- ESPR $0.88
- ONEW $15.00
- Average True Range (ATR)
- ESPR 0.07
- ONEW 0.72
- MACD
- ESPR 0.02
- ONEW 0.07
- Stochastic Oscillator
- ESPR 69.48
- ONEW 55.60
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About ONEW OneWater Marine Inc.
OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.